 Monika Headrick
Concepts (536)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 42 | 2023 | 1008 | 5.130 |
Why?
| | Erythrocytes | 28 | 2024 | 673 | 4.730 |
Why?
| | Blood Proteins | 11 | 2020 | 239 | 3.780 |
Why?
| | Proteome | 20 | 2022 | 430 | 3.510 |
Why?
| | Blood Preservation | 16 | 2024 | 270 | 3.420 |
Why?
| | Erythrocyte Transfusion | 9 | 2023 | 181 | 2.790 |
Why?
| | Hemolysis | 12 | 2024 | 199 | 2.410 |
Why?
| | Fibrinolysis | 7 | 2022 | 133 | 2.070 |
Why?
| | Extracellular Matrix Proteins | 5 | 2021 | 140 | 1.800 |
Why?
| | Extracellular Matrix | 8 | 2023 | 495 | 1.640 |
Why?
| | Mass Spectrometry | 14 | 2019 | 662 | 1.500 |
Why?
| | Chromatography, Liquid | 7 | 2017 | 377 | 1.360 |
Why?
| | Blood Coagulation Disorders | 5 | 2023 | 162 | 1.350 |
Why?
| | Mesentery | 3 | 2014 | 47 | 1.280 |
Why?
| | Wounds and Injuries | 6 | 2022 | 705 | 1.270 |
Why?
| | Anemia, Sickle Cell | 4 | 2023 | 253 | 1.220 |
Why?
| | beta-Thalassemia | 4 | 2023 | 37 | 1.120 |
Why?
| | Tandem Mass Spectrometry | 7 | 2016 | 452 | 1.100 |
Why?
| | Tissue Plasminogen Activator | 6 | 2023 | 219 | 1.080 |
Why?
| | Lymph | 3 | 2018 | 32 | 1.070 |
Why?
| | Plasma | 4 | 2017 | 199 | 1.040 |
Why?
| | Blood Coagulation | 6 | 2023 | 226 | 0.990 |
Why?
| | Tissue Scaffolds | 2 | 2019 | 199 | 0.950 |
Why?
| | Plateletpheresis | 2 | 2015 | 27 | 0.930 |
Why?
| | Survival of Motor Neuron 1 Protein | 2 | 2016 | 9 | 0.920 |
Why?
| | Blood Platelets | 4 | 2015 | 376 | 0.910 |
Why?
| | Extracellular Vesicles | 5 | 2023 | 129 | 0.880 |
Why?
| | Lipopolysaccharides | 10 | 2022 | 854 | 0.870 |
Why?
| | Reticulocytes | 1 | 2023 | 18 | 0.870 |
Why?
| | Isoantibodies | 1 | 2023 | 48 | 0.840 |
Why?
| | Blood Donors | 5 | 2024 | 96 | 0.820 |
Why?
| | Metabolome | 4 | 2021 | 319 | 0.750 |
Why?
| | Oxidative Stress | 10 | 2022 | 1181 | 0.750 |
Why?
| | Arginine | 1 | 2022 | 259 | 0.720 |
Why?
| | Humans | 81 | 2024 | 128019 | 0.700 |
Why?
| | Shock, Hemorrhagic | 5 | 2023 | 165 | 0.690 |
Why?
| | Animals | 38 | 2023 | 34487 | 0.680 |
Why?
| | Sex Characteristics | 3 | 2015 | 719 | 0.660 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 2017 | 328 | 0.660 |
Why?
| | Acellular Dermis | 1 | 2019 | 12 | 0.650 |
Why?
| | Lipid Metabolism | 2 | 2017 | 491 | 0.640 |
Why?
| | Metabolomics | 7 | 2024 | 599 | 0.620 |
Why?
| | Hypoxia | 7 | 2023 | 1034 | 0.620 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 337 | 0.610 |
Why?
| | Thrombelastography | 7 | 2023 | 147 | 0.610 |
Why?
| | Coronavirus Infections | 2 | 2020 | 333 | 0.610 |
Why?
| | Complement System Proteins | 2 | 2021 | 307 | 0.590 |
Why?
| | Hemoglobins | 4 | 2022 | 336 | 0.590 |
Why?
| | Tissue Engineering | 3 | 2019 | 394 | 0.590 |
Why?
| | Hydroxylamine | 1 | 2017 | 7 | 0.580 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2017 | 83 | 0.560 |
Why?
| | Mice | 19 | 2023 | 16574 | 0.560 |
Why?
| | Hydrogels | 4 | 2023 | 634 | 0.550 |
Why?
| | Interleukin-6 | 2 | 2020 | 712 | 0.540 |
Why?
| | Mycophenolic Acid | 1 | 2017 | 89 | 0.530 |
Why?
| | Nucleotides | 1 | 2017 | 117 | 0.520 |
Why?
| | Campylobacter jejuni | 3 | 2011 | 11 | 0.510 |
Why?
| | Coiled Bodies | 1 | 2016 | 8 | 0.510 |
Why?
| | Pandemics | 3 | 2023 | 1473 | 0.510 |
Why?
| | Microtubule-Associated Proteins | 2 | 2021 | 189 | 0.490 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.490 |
Why?
| | Myocardium | 3 | 2022 | 967 | 0.490 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2020 | 30 | 0.470 |
Why?
| | Extinction, Biological | 1 | 2015 | 32 | 0.470 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2016 | 153 | 0.460 |
Why?
| | Oxidation-Reduction | 7 | 2021 | 1001 | 0.450 |
Why?
| | Neutrophils | 4 | 2022 | 1192 | 0.440 |
Why?
| | Nanoparticles | 2 | 2022 | 368 | 0.430 |
Why?
| | Lymph Nodes | 2 | 2018 | 465 | 0.420 |
Why?
| | Proteolysis | 2 | 2017 | 162 | 0.420 |
Why?
| | Erythrocyte Deformability | 1 | 2022 | 15 | 0.410 |
Why?
| | Thrombophilia | 1 | 2023 | 66 | 0.410 |
Why?
| | Paxillin | 1 | 2022 | 10 | 0.410 |
Why?
| | Immunosuppressive Agents | 1 | 2017 | 682 | 0.410 |
Why?
| | Collagen | 1 | 2015 | 429 | 0.410 |
Why?
| | Repressor Proteins | 1 | 2016 | 399 | 0.400 |
Why?
| | Valosin Containing Protein | 1 | 2022 | 4 | 0.400 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2012 | 42 | 0.400 |
Why?
| | Superoxides | 2 | 2022 | 196 | 0.390 |
Why?
| | Oxygen | 3 | 2022 | 899 | 0.390 |
Why?
| | O Antigens | 3 | 2006 | 9 | 0.390 |
Why?
| | Cytoplasmic Dyneins | 1 | 2021 | 7 | 0.390 |
Why?
| | Intestinal Mucosa | 1 | 2017 | 575 | 0.380 |
Why?
| | Cell Proliferation | 6 | 2022 | 2337 | 0.380 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2022 | 24 | 0.380 |
Why?
| | Male | 28 | 2023 | 62757 | 0.380 |
Why?
| | Nervous System Malformations | 1 | 2022 | 37 | 0.370 |
Why?
| | Glycolysis | 4 | 2022 | 293 | 0.370 |
Why?
| | Carnitine | 1 | 2022 | 76 | 0.370 |
Why?
| | Biomarkers | 8 | 2022 | 3874 | 0.370 |
Why?
| | Plesiomonas | 3 | 2006 | 3 | 0.370 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 815 | 0.360 |
Why?
| | Gangliosides | 1 | 2011 | 19 | 0.360 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 189 | 0.350 |
Why?
| | Female | 27 | 2023 | 68016 | 0.350 |
Why?
| | Endosomes | 1 | 2021 | 126 | 0.350 |
Why?
| | Resuscitation | 3 | 2017 | 234 | 0.320 |
Why?
| | Proteins | 2 | 2023 | 933 | 0.320 |
Why?
| | Breast Neoplasms | 3 | 2022 | 2131 | 0.320 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2019 | 45 | 0.320 |
Why?
| | Thrombosis | 1 | 2022 | 323 | 0.320 |
Why?
| | Glioblastoma | 1 | 2022 | 323 | 0.320 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 44 | 0.320 |
Why?
| | Molecular Sequence Data | 9 | 2015 | 2820 | 0.310 |
Why?
| | Biological Products | 1 | 2022 | 198 | 0.310 |
Why?
| | Androgen Antagonists | 1 | 2019 | 79 | 0.310 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 391 | 0.310 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 94 | 0.310 |
Why?
| | Protein Processing, Post-Translational | 3 | 2019 | 451 | 0.300 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1185 | 0.300 |
Why?
| | Cells, Cultured | 7 | 2021 | 4006 | 0.300 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 337 | 0.300 |
Why?
| | Androgens | 1 | 2019 | 173 | 0.290 |
Why?
| | Adult | 18 | 2023 | 35176 | 0.290 |
Why?
| | Energy Metabolism | 3 | 2022 | 831 | 0.280 |
Why?
| | Hematopoietic Stem Cells | 1 | 2021 | 379 | 0.280 |
Why?
| | Lymphokines | 1 | 2017 | 115 | 0.280 |
Why?
| | Leukocyte Reduction Procedures | 2 | 2018 | 25 | 0.280 |
Why?
| | Ketones | 1 | 2017 | 47 | 0.280 |
Why?
| | Asparagine | 2 | 2018 | 29 | 0.270 |
Why?
| | Inflammation | 7 | 2023 | 2646 | 0.270 |
Why?
| | Middle Aged | 14 | 2023 | 30812 | 0.270 |
Why?
| | alpha 1-Antitrypsin | 2 | 2022 | 102 | 0.270 |
Why?
| | Chondrogenesis | 2 | 2020 | 82 | 0.270 |
Why?
| | Apocrine Glands | 1 | 2016 | 4 | 0.270 |
Why?
| | Hemorrhage | 4 | 2023 | 643 | 0.260 |
Why?
| | Transcriptome | 3 | 2022 | 879 | 0.260 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 24 | 0.260 |
Why?
| | Aldehydes | 1 | 2017 | 138 | 0.260 |
Why?
| | Rats | 7 | 2023 | 5199 | 0.260 |
Why?
| | Neutrophil Activation | 2 | 2018 | 78 | 0.260 |
Why?
| | Cell Line, Tumor | 7 | 2022 | 3168 | 0.260 |
Why?
| | Time Factors | 6 | 2018 | 6479 | 0.260 |
Why?
| | Glycolipids | 1 | 2016 | 42 | 0.260 |
Why?
| | Lung | 3 | 2015 | 3745 | 0.250 |
Why?
| | Molecular Chaperones | 1 | 2017 | 181 | 0.250 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2022 | 562 | 0.250 |
Why?
| | Injury Severity Score | 2 | 2018 | 509 | 0.250 |
Why?
| | Milk | 1 | 2016 | 119 | 0.250 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2017 | 510 | 0.240 |
Why?
| | Multiple Organ Failure | 2 | 2022 | 122 | 0.240 |
Why?
| | Electrophoresis, Capillary | 3 | 2008 | 20 | 0.240 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2019 | 744 | 0.230 |
Why?
| | Protein Conformation | 1 | 2017 | 853 | 0.230 |
Why?
| | Glycoproteins | 1 | 2016 | 337 | 0.230 |
Why?
| | Cell Membrane | 2 | 2016 | 725 | 0.220 |
Why?
| | Ubiquitination | 2 | 2016 | 98 | 0.220 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 2042 | 0.220 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2015 | 115 | 0.220 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 11 | 0.220 |
Why?
| | Blood Group Antigens | 1 | 2023 | 16 | 0.220 |
Why?
| | Bacteria | 2 | 2022 | 812 | 0.220 |
Why?
| | Brain Neoplasms | 1 | 2022 | 1163 | 0.220 |
Why?
| | Epitopes | 3 | 2008 | 466 | 0.220 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2022 | 281 | 0.220 |
Why?
| | Interferons | 2 | 2022 | 192 | 0.210 |
Why?
| | Birth Injuries | 1 | 2023 | 10 | 0.210 |
Why?
| | Hypocalcemia | 1 | 2023 | 28 | 0.210 |
Why?
| | Swine | 3 | 2023 | 742 | 0.210 |
Why?
| | Reactive Oxygen Species | 5 | 2022 | 582 | 0.210 |
Why?
| | Glucose | 3 | 2018 | 983 | 0.210 |
Why?
| | Proteasome Endopeptidase Complex | 3 | 2022 | 145 | 0.210 |
Why?
| | Haemophilus influenzae | 2 | 2008 | 63 | 0.210 |
Why?
| | Acute-Phase Proteins | 2 | 2014 | 67 | 0.210 |
Why?
| | Sphingosine | 1 | 2023 | 36 | 0.210 |
Why?
| | Solubility | 2 | 2017 | 232 | 0.210 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 45 | 0.200 |
Why?
| | DNA Modification Methylases | 1 | 2022 | 15 | 0.200 |
Why?
| | Carbohydrate Sequence | 7 | 2008 | 24 | 0.200 |
Why?
| | Platelet Transfusion | 1 | 2023 | 59 | 0.200 |
Why?
| | Serpins | 1 | 2022 | 31 | 0.200 |
Why?
| | Lysophospholipids | 1 | 2023 | 68 | 0.200 |
Why?
| | Arginase | 1 | 2022 | 32 | 0.200 |
Why?
| | Blood Banks | 2 | 2021 | 40 | 0.200 |
Why?
| | Erythroblasts | 1 | 2022 | 15 | 0.200 |
Why?
| | Rejuvenation | 2 | 2021 | 18 | 0.200 |
Why?
| | Protein Transport | 2 | 2021 | 420 | 0.200 |
Why?
| | Citrulline | 1 | 2022 | 43 | 0.200 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2022 | 55 | 0.200 |
Why?
| | beta-Globins | 1 | 2022 | 8 | 0.190 |
Why?
| | Signal Transduction | 6 | 2022 | 4812 | 0.190 |
Why?
| | Fibrinolysin | 1 | 2022 | 17 | 0.190 |
Why?
| | Case-Control Studies | 5 | 2022 | 3324 | 0.190 |
Why?
| | Isoaspartic Acid | 1 | 2021 | 3 | 0.190 |
Why?
| | Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2021 | 5 | 0.190 |
Why?
| | Endothelial Cells | 3 | 2023 | 700 | 0.190 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2021 | 22 | 0.190 |
Why?
| | Blood | 1 | 2022 | 99 | 0.190 |
Why?
| | Macrophages | 4 | 2023 | 1460 | 0.190 |
Why?
| | Methods | 2 | 2018 | 64 | 0.180 |
Why?
| | Cell Cycle Proteins | 3 | 2022 | 578 | 0.180 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2015 | 377 | 0.180 |
Why?
| | Receptors, Glucocorticoid | 1 | 2022 | 148 | 0.180 |
Why?
| | Erythrocyte Membrane | 1 | 2021 | 49 | 0.180 |
Why?
| | Virulence Factors | 1 | 2022 | 152 | 0.180 |
Why?
| | Hypertension, Pulmonary | 2 | 2022 | 1747 | 0.180 |
Why?
| | Betacoronavirus | 2 | 2020 | 247 | 0.180 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.180 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 34 | 0.180 |
Why?
| | Saccharomyces cerevisiae | 2 | 2015 | 524 | 0.170 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 257 | 0.170 |
Why?
| | Thrombin | 3 | 2023 | 143 | 0.170 |
Why?
| | Aging | 3 | 2021 | 1745 | 0.170 |
Why?
| | Databases, Genetic | 1 | 2021 | 228 | 0.170 |
Why?
| | Lipid A | 2 | 2008 | 29 | 0.170 |
Why?
| | Membrane Lipids | 1 | 2020 | 90 | 0.170 |
Why?
| | Cell Line | 5 | 2018 | 2736 | 0.170 |
Why?
| | Spermatogenesis | 1 | 2020 | 62 | 0.170 |
Why?
| | Antibodies, Bacterial | 2 | 2008 | 136 | 0.170 |
Why?
| | Protein Stability | 2 | 2017 | 159 | 0.160 |
Why?
| | Parabiosis | 1 | 2019 | 10 | 0.160 |
Why?
| | Dyneins | 1 | 2019 | 30 | 0.160 |
Why?
| | Altitude | 1 | 2023 | 451 | 0.160 |
Why?
| | Oligosaccharides | 3 | 2006 | 57 | 0.160 |
Why?
| | Adenosine Triphosphatases | 2 | 2022 | 161 | 0.160 |
Why?
| | Semen Analysis | 2 | 2020 | 13 | 0.160 |
Why?
| | Nitric Oxide | 2 | 2022 | 881 | 0.160 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5268 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 3 | 2022 | 175 | 0.150 |
Why?
| | Fertility | 1 | 2020 | 159 | 0.150 |
Why?
| | Infertility, Male | 2 | 2020 | 60 | 0.150 |
Why?
| | Aspartic Acid | 1 | 2018 | 78 | 0.150 |
Why?
| | Proteus penneri | 1 | 2008 | 1 | 0.150 |
Why?
| | Mice, Knockout | 2 | 2023 | 2757 | 0.150 |
Why?
| | Mitochondria | 2 | 2022 | 847 | 0.150 |
Why?
| | Blood Transfusion | 3 | 2022 | 291 | 0.150 |
Why?
| | Spermatozoa | 2 | 2020 | 91 | 0.150 |
Why?
| | Myocytes, Cardiac | 1 | 2022 | 492 | 0.150 |
Why?
| | Sodium Chloride | 2 | 2015 | 138 | 0.150 |
Why?
| | Basophils | 1 | 2018 | 72 | 0.150 |
Why?
| | Anti-Allergic Agents | 1 | 2018 | 45 | 0.140 |
Why?
| | Omalizumab | 1 | 2018 | 50 | 0.140 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.140 |
Why?
| | Protons | 2 | 2007 | 80 | 0.140 |
Why?
| | Acetylation | 4 | 2019 | 242 | 0.140 |
Why?
| | Urticaria | 1 | 2018 | 37 | 0.140 |
Why?
| | Trastuzumab | 2 | 2022 | 100 | 0.140 |
Why?
| | Fibrinolytic Agents | 2 | 2022 | 248 | 0.140 |
Why?
| | Immune Sera | 2 | 2004 | 86 | 0.140 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.140 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 83 | 0.130 |
Why?
| | Microtubules | 1 | 2019 | 259 | 0.130 |
Why?
| | Freeze Drying | 1 | 2017 | 82 | 0.130 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2018 | 541 | 0.130 |
Why?
| | Preoperative Period | 1 | 2017 | 113 | 0.130 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.130 |
Why?
| | Purines | 1 | 2017 | 168 | 0.130 |
Why?
| | Fibroblasts | 1 | 2021 | 934 | 0.130 |
Why?
| | DNA | 2 | 2022 | 1392 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 38 | 0.130 |
Why?
| | Isotope Labeling | 1 | 2017 | 73 | 0.130 |
Why?
| | Apoptosis | 3 | 2022 | 2425 | 0.130 |
Why?
| | Healthy Volunteers | 1 | 2017 | 199 | 0.130 |
Why?
| | Mammals | 3 | 2022 | 268 | 0.130 |
Why?
| | Pancreas | 1 | 2018 | 304 | 0.130 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1681 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2258 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 115 | 0.130 |
Why?
| | Epithelial Cells | 2 | 2016 | 1037 | 0.130 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2016 | 21 | 0.130 |
Why?
| | Receptor, PAR-2 | 1 | 2015 | 6 | 0.120 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 148 | 0.120 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2015 | 26 | 0.120 |
Why?
| | Workflow | 1 | 2017 | 154 | 0.120 |
Why?
| | Bison | 1 | 2015 | 6 | 0.120 |
Why?
| | Plasminogen | 1 | 2015 | 31 | 0.120 |
Why?
| | Chemical Fractionation | 1 | 2015 | 29 | 0.120 |
Why?
| | Microcirculation | 1 | 2015 | 137 | 0.120 |
Why?
| | Myocardial Infarction | 1 | 2022 | 1013 | 0.120 |
Why?
| | Gelsolin | 1 | 2014 | 9 | 0.120 |
Why?
| | Hafnia alvei | 1 | 2004 | 1 | 0.120 |
Why?
| | Kallikreins | 1 | 2014 | 29 | 0.120 |
Why?
| | Glycosylation | 1 | 2015 | 149 | 0.120 |
Why?
| | Glutamine | 1 | 2015 | 94 | 0.120 |
Why?
| | Serine Proteases | 1 | 2014 | 20 | 0.120 |
Why?
| | Bacterial Proteins | 4 | 2022 | 823 | 0.120 |
Why?
| | Blood Component Transfusion | 1 | 2015 | 79 | 0.110 |
Why?
| | Rats, Inbred F344 | 1 | 2015 | 251 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2007 | 167 | 0.110 |
Why?
| | Aquaporin 4 | 1 | 2015 | 95 | 0.110 |
Why?
| | Skull | 1 | 2015 | 128 | 0.110 |
Why?
| | Complex Mixtures | 1 | 2014 | 11 | 0.110 |
Why?
| | Organ Size | 1 | 2015 | 440 | 0.110 |
Why?
| | Peptide Hydrolases | 1 | 2014 | 106 | 0.110 |
Why?
| | Homeostasis | 2 | 2022 | 605 | 0.110 |
Why?
| | Muscle, Skeletal | 2 | 2023 | 1619 | 0.110 |
Why?
| | Blotting, Western | 2 | 2011 | 1169 | 0.110 |
Why?
| | Glycoconjugates | 1 | 2003 | 8 | 0.110 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 134 | 0.110 |
Why?
| | Prognosis | 2 | 2022 | 3766 | 0.110 |
Why?
| | Tetanus Toxoid | 1 | 2003 | 37 | 0.110 |
Why?
| | Neural Stem Cells | 1 | 2015 | 141 | 0.110 |
Why?
| | Thromboplastin | 1 | 2023 | 69 | 0.100 |
Why?
| | Cluster Analysis | 1 | 2014 | 477 | 0.100 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 128 | 0.100 |
Why?
| | Stem Cell Niche | 1 | 2013 | 51 | 0.100 |
Why?
| | Pilot Projects | 1 | 2018 | 1559 | 0.100 |
Why?
| | Survival of Motor Neuron 2 Protein | 1 | 2012 | 3 | 0.100 |
Why?
| | Cumulus Cells | 1 | 2012 | 6 | 0.100 |
Why?
| | Pyruvates | 1 | 2022 | 23 | 0.100 |
Why?
| | Inosine | 1 | 2022 | 12 | 0.100 |
Why?
| | Central Nervous System | 1 | 2015 | 254 | 0.100 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2012 | 14 | 0.100 |
Why?
| | Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 4 | 0.100 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2022 | 28 | 0.100 |
Why?
| | Acute Lung Injury | 2 | 2015 | 264 | 0.100 |
Why?
| | Lymphoid Tissue | 1 | 2022 | 68 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 504 | 0.100 |
Why?
| | Leukocyte Count | 1 | 2013 | 325 | 0.100 |
Why?
| | Endotoxins | 1 | 2003 | 215 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 186 | 0.100 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2022 | 9 | 0.100 |
Why?
| | Maternal Age | 1 | 2012 | 123 | 0.100 |
Why?
| | Catalase | 1 | 2022 | 128 | 0.100 |
Why?
| | Ubiquitin | 1 | 2022 | 62 | 0.100 |
Why?
| | Quality Control | 1 | 2022 | 156 | 0.100 |
Why?
| | Young Adult | 4 | 2021 | 12281 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 311 | 0.090 |
Why?
| | Oxygen Consumption | 1 | 2014 | 669 | 0.090 |
Why?
| | beta 2-Microglobulin | 1 | 2011 | 47 | 0.090 |
Why?
| | RNA-Binding Proteins | 1 | 2015 | 388 | 0.090 |
Why?
| | Phosphates | 1 | 2022 | 169 | 0.090 |
Why?
| | Leukocytes | 1 | 2013 | 303 | 0.090 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 493 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2022 | 109 | 0.090 |
Why?
| | Transfusion Reaction | 1 | 2011 | 41 | 0.090 |
Why?
| | Histones | 2 | 2022 | 585 | 0.090 |
Why?
| | Transglutaminases | 1 | 2022 | 153 | 0.090 |
Why?
| | Galactosyltransferases | 1 | 2011 | 11 | 0.090 |
Why?
| | Sialyltransferases | 1 | 2011 | 13 | 0.090 |
Why?
| | Disease Models, Animal | 4 | 2023 | 3936 | 0.090 |
Why?
| | HeLa Cells | 1 | 2012 | 605 | 0.090 |
Why?
| | Linoleic Acid | 1 | 2021 | 41 | 0.090 |
Why?
| | Adenosine | 1 | 2022 | 212 | 0.090 |
Why?
| | Lipids | 2 | 2023 | 619 | 0.090 |
Why?
| | Mice, SCID | 1 | 2021 | 350 | 0.090 |
Why?
| | Cell Self Renewal | 1 | 2021 | 52 | 0.090 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2006 | 136 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2015 | 842 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 817 | 0.080 |
Why?
| | Astrocytes | 1 | 2022 | 188 | 0.080 |
Why?
| | Rabbits | 3 | 2014 | 761 | 0.080 |
Why?
| | Substrate Specificity | 1 | 2011 | 366 | 0.080 |
Why?
| | HEK293 Cells | 1 | 2012 | 681 | 0.080 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 586 | 0.080 |
Why?
| | DNA Damage | 1 | 2022 | 363 | 0.080 |
Why?
| | Risk Factors | 1 | 2023 | 9696 | 0.080 |
Why?
| | Phenylthiohydantoin | 1 | 2019 | 44 | 0.080 |
Why?
| | Bordetella pertussis | 1 | 2009 | 2 | 0.080 |
Why?
| | B-Lymphocytes | 1 | 2015 | 812 | 0.080 |
Why?
| | Peptides | 1 | 2015 | 910 | 0.080 |
Why?
| | Glucosamine | 1 | 2009 | 13 | 0.080 |
Why?
| | Models, Molecular | 2 | 2020 | 1482 | 0.080 |
Why?
| | Phenotype | 1 | 2017 | 3039 | 0.080 |
Why?
| | Multiple Myeloma | 1 | 2021 | 125 | 0.080 |
Why?
| | Escherichia coli | 1 | 2003 | 766 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 873 | 0.080 |
Why?
| | Nitriles | 1 | 2019 | 159 | 0.080 |
Why?
| | Miller Fisher Syndrome | 1 | 2008 | 2 | 0.080 |
Why?
| | Benzamides | 1 | 2019 | 195 | 0.080 |
Why?
| | Histone Acetyltransferases | 1 | 2019 | 63 | 0.080 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 245 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4853 | 0.080 |
Why?
| | Guillain-Barre Syndrome | 1 | 2008 | 22 | 0.080 |
Why?
| | Membrane Glycoproteins | 1 | 2011 | 467 | 0.080 |
Why?
| | Multigene Family | 1 | 2009 | 198 | 0.070 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2007 | 11 | 0.070 |
Why?
| | Pregnancy | 3 | 2023 | 6355 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1421 | 0.070 |
Why?
| | Membrane Proteins | 2 | 2020 | 1105 | 0.070 |
Why?
| | Cell Adhesion | 2 | 2020 | 444 | 0.070 |
Why?
| | Unfolded Protein Response | 1 | 2017 | 52 | 0.070 |
Why?
| | Critical Illness | 1 | 2013 | 755 | 0.070 |
Why?
| | Hydrolysis | 1 | 2017 | 184 | 0.070 |
Why?
| | Molecular Weight | 1 | 2017 | 331 | 0.070 |
Why?
| | Protein Aggregates | 1 | 2017 | 67 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2011 | 730 | 0.070 |
Why?
| | Protein Binding | 2 | 2017 | 2105 | 0.070 |
Why?
| | Glycine | 1 | 2007 | 163 | 0.070 |
Why?
| | Butyrophilins | 1 | 2016 | 6 | 0.070 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 137 | 0.070 |
Why?
| | Obesity | 1 | 2020 | 2859 | 0.070 |
Why?
| | Lipid Droplets | 1 | 2016 | 22 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2015 | 1140 | 0.070 |
Why?
| | Cross Reactions | 2 | 2008 | 129 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3009 | 0.060 |
Why?
| | Aged | 4 | 2021 | 21892 | 0.060 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 64 | 0.060 |
Why?
| | Prospective Studies | 1 | 2017 | 7035 | 0.060 |
Why?
| | Cytoplasm | 1 | 2016 | 257 | 0.060 |
Why?
| | Lactation | 1 | 2016 | 170 | 0.060 |
Why?
| | Methylation | 2 | 2018 | 227 | 0.060 |
Why?
| | Monocytes | 2 | 2023 | 546 | 0.060 |
Why?
| | Models, Chemical | 2 | 2006 | 263 | 0.060 |
Why?
| | Chromosome Segregation | 2 | 2015 | 40 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 195 | 0.060 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.060 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2023 | 32 | 0.060 |
Why?
| | Pelvic Floor | 1 | 2023 | 23 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 105 | 0.050 |
Why?
| | Brain | 1 | 2015 | 2615 | 0.050 |
Why?
| | Molecular Structure | 2 | 2009 | 465 | 0.050 |
Why?
| | Cohort Studies | 1 | 2023 | 5378 | 0.050 |
Why?
| | Angiopoietins | 1 | 2022 | 13 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 69 | 0.050 |
Why?
| | Thymidine | 1 | 2022 | 59 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 59 | 0.050 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2022 | 43 | 0.050 |
Why?
| | Random Allocation | 1 | 2023 | 342 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 51 | 0.050 |
Why?
| | alpha-Globins | 1 | 2022 | 9 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 68 | 0.050 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 60 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 49 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2022 | 228 | 0.050 |
Why?
| | Mutation | 1 | 2022 | 3682 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 258 | 0.050 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 226 | 0.050 |
Why?
| | Membrane Microdomains | 1 | 2021 | 31 | 0.050 |
Why?
| | Least-Squares Analysis | 1 | 2021 | 72 | 0.050 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 30 | 0.050 |
Why?
| | Chromatin | 2 | 2015 | 477 | 0.050 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.040 |
Why?
| | Bacteriophage lambda | 1 | 2021 | 88 | 0.040 |
Why?
| | Fibrosis | 1 | 2023 | 513 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 155 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 638 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 539 | 0.040 |
Why?
| | Fatty Acids | 1 | 2023 | 415 | 0.040 |
Why?
| | Sulfhydryl Compounds | 1 | 2022 | 186 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 109 | 0.040 |
Why?
| | Phosphorylation | 2 | 2015 | 1681 | 0.040 |
Why?
| | Adolescent | 2 | 2020 | 20158 | 0.040 |
Why?
| | Sperm Count | 1 | 2020 | 17 | 0.040 |
Why?
| | Heterozygote | 1 | 2021 | 267 | 0.040 |
Why?
| | Sperm Motility | 1 | 2020 | 30 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 185 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 163 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2020 | 1896 | 0.040 |
Why?
| | Tissue Survival | 1 | 2018 | 16 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 477 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2022 | 467 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2021 | 325 | 0.040 |
Why?
| | Pepsin A | 1 | 2018 | 19 | 0.040 |
Why?
| | Cell Communication | 1 | 2020 | 297 | 0.040 |
Why?
| | Blood Buffy Coat | 1 | 2018 | 4 | 0.040 |
Why?
| | Sulfates | 1 | 2018 | 49 | 0.040 |
Why?
| | NF-kappa B | 1 | 2022 | 649 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2018 | 84 | 0.040 |
Why?
| | Filtration | 1 | 2018 | 64 | 0.040 |
Why?
| | Fluorescence | 1 | 2018 | 160 | 0.040 |
Why?
| | Solutions | 1 | 2018 | 148 | 0.040 |
Why?
| | Bacteriological Techniques | 1 | 2018 | 68 | 0.040 |
Why?
| | Deamination | 1 | 2017 | 5 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 365 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 464 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 604 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 488 | 0.040 |
Why?
| | Calcium | 1 | 2023 | 1182 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 20 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1330 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 22 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2020 | 589 | 0.030 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2006 | 89 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1537 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 577 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 95 | 0.030 |
Why?
| | Amides | 1 | 2006 | 90 | 0.030 |
Why?
| | Chromatids | 1 | 2015 | 8 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2598 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 283 | 0.030 |
Why?
| | HMGA2 Protein | 1 | 2015 | 9 | 0.030 |
Why?
| | Bromodeoxyuridine | 1 | 2015 | 77 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2015 | 37 | 0.030 |
Why?
| | Chromosomes | 1 | 2015 | 101 | 0.030 |
Why?
| | Electroporation | 1 | 2015 | 37 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 441 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 675 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 133 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 2004 | 15 | 0.030 |
Why?
| | Tranexamic Acid | 1 | 2015 | 36 | 0.030 |
Why?
| | Immunoglobulin Light Chains | 1 | 2015 | 40 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 157 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 231 | 0.030 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2015 | 80 | 0.030 |
Why?
| | Serologic Tests | 1 | 2004 | 50 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 541 | 0.030 |
Why?
| | Seminal Plasma Proteins | 1 | 2014 | 10 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 891 | 0.030 |
Why?
| | Chromosomal Instability | 1 | 2014 | 18 | 0.030 |
Why?
| | Embryo Implantation | 1 | 2014 | 27 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 323 | 0.030 |
Why?
| | Fetal Stem Cells | 1 | 2013 | 8 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2014 | 76 | 0.030 |
Why?
| | DNA Repair | 1 | 2015 | 205 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1689 | 0.030 |
Why?
| | Embryonic Development | 1 | 2014 | 114 | 0.030 |
Why?
| | Species Specificity | 1 | 2004 | 568 | 0.030 |
Why?
| | Amino Acids | 1 | 2017 | 476 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1047 | 0.030 |
Why?
| | Synovial Membrane | 1 | 2013 | 90 | 0.030 |
Why?
| | Microscopy, Atomic Force | 1 | 2013 | 115 | 0.030 |
Why?
| | Cell Count | 1 | 2013 | 310 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 251 | 0.030 |
Why?
| | Oocyte Donation | 1 | 2012 | 4 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 370 | 0.030 |
Why?
| | Immunoblotting | 1 | 2003 | 301 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 933 | 0.020 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 271 | 0.020 |
Why?
| | Silver Staining | 1 | 2002 | 17 | 0.020 |
Why?
| | Disaccharides | 1 | 2002 | 18 | 0.020 |
Why?
| | Chronic Disease | 1 | 2018 | 1690 | 0.020 |
Why?
| | Wnt Signaling Pathway | 1 | 2013 | 165 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2260 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2057 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 344 | 0.020 |
Why?
| | Cell Cycle | 1 | 2014 | 580 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1343 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1077 | 0.020 |
Why?
| | Antibodies | 1 | 2002 | 392 | 0.020 |
Why?
| | Gene Order | 1 | 2009 | 26 | 0.020 |
Why?
| | Glycosyltransferases | 1 | 2009 | 14 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1264 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 65 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1828 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2008 | 15 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2008 | 22 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2009 | 108 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2009 | 158 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2008 | 23 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 1984 | 0.020 |
Why?
| | Microwaves | 1 | 2008 | 35 | 0.020 |
Why?
| | Acylation | 1 | 2007 | 28 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2008 | 323 | 0.020 |
Why?
| | Child | 1 | 2023 | 20636 | 0.010 |
Why?
|
|
Headrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|